Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 7(113), p. 1027-1034, 2015
DOI: 10.1038/bjc.2015.329
Links
- ORCID
- ORCID
- ORCID
- Springer Nature [academic journals on nature.com] | PDF
- ORCID
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net]
Tools
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting
Journal article published in 2015 by
Diether Lambrechts 
,
Bernard Thienpont ,
Vincent Thuillier,
Xavier Sagaert,
Matthieu Moisse ,
Gilian Peuteman,
Carles Pericay,
Gunnar Folprecht,
John Zalcberg ,
Chiara Zilocchi,
Emmanuelle Margherini,
Marielle Chiron,
Eric Van Cutsem
,
Bernard Thienpont ,
Vincent Thuillier,
Xavier Sagaert,
Matthieu Moisse ,
Gilian Peuteman,
Carles Pericay,
Gunnar Folprecht,
John Zalcberg ,
Chiara Zilocchi,
Emmanuelle Margherini,
Marielle Chiron,
Eric Van Cutsem
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 